Rigel Pharmaceuticals (RIGL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2013 | 03-2013 | 12-2012 | 09-2012 | 06-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -48,342 | -25,574 | -98,840 | -73,368 | -47,912 |
| Depreciation Amortization | 1,297 | 669 | 2,433 | 1,797 | 1,162 |
| Accounts payable and accrued liabilities | 424 | 441 | 141 | -168 | 356 |
| Other Working Capital | -2,927 | -1,999 | -1,402 | -1,421 | -3,372 |
| Other Operating Activity | 3,116 | 1,352 | 12,459 | 9,522 | 5,753 |
| Operating Cash Flow | $-46,432 | $-25,111 | $-85,209 | $-63,638 | $-44,013 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 34,919 | 26,462 | -35,674 | 72,013 | 52,550 |
| PPE Investments | -925 | -676 | -3,360 | -2,776 | -2,392 |
| Investing Cash Flow | $33,994 | $25,786 | $-39,034 | $69,237 | $50,158 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 822 | N/A | 139,094 | 2,569 | 1,373 |
| Financing Cash Flow | $822 | $N/A | $139,094 | $2,569 | $1,373 |
| Beginning Cash Position | 33,484 | 33,484 | 18,633 | 18,633 | 18,633 |
| End Cash Position | 21,868 | 34,159 | 33,484 | 26,801 | 26,151 |
| Net Cash Flow | $-11,616 | $675 | $14,851 | $8,168 | $7,518 |
| Free Cash Flow | |||||
| Operating Cash Flow | -46,432 | -25,111 | -85,209 | -63,638 | -44,013 |
| Capital Expenditure | -925 | -676 | -3,377 | -2,776 | -2,392 |
| Free Cash Flow | -47,357 | -25,787 | -88,586 | -66,414 | -46,405 |